Amanda is a strategic advisor to life sciences and technology companies, guiding them through complex transactions and pivotal stages of growth—from early financings to IPOs and life as a public company. She brings a practical, business-oriented approach to her work, helping clients navigate capital markets, corporate governance, and regulatory compliance with clarity and confidence.

Amanda represents both private and public companies in a broad range of capital markets and corporate transactions, including venture financings, initial public offerings, follow-on and secondary offerings, SPACs, PIPEs, at-the-market offerings, and preferred equity and debt financings. She is also a trusted counselor to late-stage private companies and public company boards on corporate governance, SEC reporting and disclosure matters, and stock exchange compliance.

Recognized by Chambers USA as a leading capital markets lawyer and named among the top U.S. lawyers in capital markets and healthcare: life sciences by The Legal 500, Amanda is known for her deep industry knowledge and her ability to help clients advance their strategic goals while managing risk.